Ptc Therapeutics PTCT
NASDAQ PTCT
$64.91 +0.77 (+1.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Ptc Therapeutics (PTCT) Asset Writedowns and Impairment (2023 - 2026)

Updated

Analysis

Ptc Therapeutics (PTCT) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Ptc Therapeutics 5.36 Bn -2.84 Bn 334.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 927,000.00
Dec 31, 2025 500,000.00
Sep 30, 2025 400,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 77,000.00
Dec 31, 2024 158.06 Mn
Jun 30, 2024 200,000.00
Jun 30, 2023 217.80 Mn
API Access

Ptc Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=PTCT&period=max&api_key=YOUR_API_KEY